Regulation of cytokine polarization and T cell recruitment to inflamed paws in mouse collagen-induced arthritis by the chemokine receptor CXCR6

Arthritis and Rheumatology

Volumn 66, Issue 11, 2014, Pages 3001-3012

  Slauenwhite, Drew ^a   Gebremeskel, Simon ^a   Doucette, Carolyn D ^a   Hoskin, David W ^a   Johnston, Brent ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR6; GAMMA INTERFERON; IMMUNOGLOBULIN G2A ANTIBODY; INTERLEUKIN 17; CHEMOKINE RECEPTOR CXCR; CXCR6 PROTEIN, MOUSE; CYTOKINE; IMMUNOGLOBULIN G;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CELL HOMING; CONTROLLED STUDY; CYTOKINE POLARIZATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; INGUINAL LYMPH NODE; MOUSE; NONHUMAN; PAW; POPLITEAL LYMPH NODE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UPREGULATION; ANIMAL; C57BL MOUSE; CELL MOTION; DEFICIENCY; DISEASE MODEL; EXPERIMENTAL ARTHRITIS; GENETICS; IN VITRO STUDY; INCIDENCE; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SEVERITY OF ILLNESS INDEX;

ANIMALS; ARTHRITIS, EXPERIMENTAL; CELL MOVEMENT; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOGLOBULIN G; IN VITRO TECHNIQUES; INCIDENCE; INTERFERON-GAMMA; INTERLEUKIN-17; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, CXCR; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES; UP-REGULATION;

EID: 84925582247     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38816     Document Type: Article

References (50)

1. Smeets TJ, Dolhain RJ, Breedveld FC, Tak PP,. Analysis of the cellular infiltrates and expression of cytokines in synovial tissue from patients with rheumatoid arthritis and reactive arthritis. J Pathol 1998; 186: 75-81.
2. Mulherin D, Fitzgerald O, Bresnihan B,. Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum 1996; 39: 115-24.
3. Nanki T, Shimaoka T, Hayashida K, Taniguchi K, Yonehara S, Miyasaka N,. Pathogenic role of the CXCL16-CXCR6 pathway in rheumatoid arthritis. Arthritis Rheum 2005; 52: 3004-14.
4. Ruth JH, Haas CS, Park CC, Amin MA, Martinez RJ, Haines GK III, et al., CXCL16-mediated cell recruitment to rheumatoid arthritis synovial tissue and murine lymph nodes is dependent upon the MAPK pathway. Arthritis Rheum 2006; 54: 765-78.
5. Van der Voort R, van Lieshout AW, Toonen LW, Sloetjes AW, van den Berg WB, Figdor CG, et al., Elevated CXCL16 expression by synovial macrophages recruits memory T cells into rheumatoid joints. Arthritis Rheum 2005; 52: 1381-91.
6. Kim CH, Kunkel EJ, Boisvert J, Johnston B, Campbell JJ, Genovese MC, et al., Bonzo/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential. J Clin Invest 2001; 107: 595-601.
7. Martini G, Cabrelle A, Calabrese F, Carraro S, Scquizzato E, Teramo A, et al., CXCR6-CXCL16 interaction in the pathogenesis of juvenile idiopathic arthritis. Clin Immunol 2008; 129: 268-76.
8. Matloubian M, David A, Engel S, Ryan JE, Cyster JG,. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat Immunol 2000; 1: 298-304.
9. Wilbanks A, Zondlo SC, Murphy K, Mak S, Soler D, Langdon P, et al., Expression cloning of the STRL33/BONZO/TYMSTR ligand reveals elements of CC, CXC, and CX3C chemokines. J Immunol 2001; 166: 5145-54.
10. Shimaoka T, Kume N, Minami M, Hayashida K, Kataoka H, Kita T, et al., Molecular cloning of a novel scavenger receptor for oxidized low density lipoprotein, SR-PSOX, on macrophages. J Biol Chem 2000; 275: 40663-6.
11. Shimaoka T, Nakayama T, Kume N, Takahashi S, Yamaguchi J, Minami M, et al., Cutting edge: SR-PSOX/CXC chemokine ligand 16 mediates bacterial phagocytosis by APCs through its chemokine domain. J Immunol 2003; 171: 1647-51.
12. Shimaoka T, Nakayama T, Fukumoto N, Kume N, Takahashi S, Yamaguchi J, et al., Cell surface-anchored SR-PSOX/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cells. J Leukoc Biol 2004; 75: 267-74.
13. Gough PJ, Garton KJ, Wille PT, Rychlewski M, Dempsey PJ, Raines EW,. A disintegrin and metalloproteinase 10-mediated cleavage and shedding regulates the cell surface expression of CXC chemokine ligand 16. J Immunol 2004; 172: 3678-85.
14. Van der Voort R, Verweij V, de Witte TM, Lasonder E, Adema GJ, Dolstra H,. An alternatively spliced CXCL16 isoform expressed by dendritic cells is a secreted chemoattractant for CXCR6+ cells. J Leukoc Biol 2010; 87: 1029-39.
15. Lim HW, Lee J, Hillsamer P, Kim CH,. Human Th17 cells share major trafficking receptors with both polarized effector T cells and FOXP3+ regulatory T cells. J Immunol 2008; 180: 122-9.
16. Unutmaz D, Xiang W, Sunshine MJ, Campbell J, Butcher E, Littman DR,. The primate lentiviral receptor Bonzo/STRL33 is coordinately regulated with CCR5 and its expression pattern is conserved between human and mouse. J Immunol 2000; 165: 3284-92.
17. Germanov E, Veinotte L, Cullen R, Chamberlain E, Butcher EC, Johnston B,. Critical role for the chemokine receptor CXCR6 in homeostasis and activation of CD1d-restricted NKT cells. J Immunol 2008; 181: 81-91.
18. Salcedo R, Resau JH, Halverson D, Hudson EA, Dambach M, Powell D, et al., Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells. FASEB J 2000; 14: 2055-64.
19. Szabo I, Wetzel MA, Rogers TJ,. Cell-density-regulated chemotactic responsiveness of keratinocytes in vitro. J Invest Dermatol 2001; 117: 1083-90.
20. Shahrara S, Huang Q, Mandelin AM II, Pope RM,. Th-17 cells in rheumatoid arthritis. Arthritis Res Ther 2008; 10: R93.
21. Yamada H, Nakashima Y, Okazaki K, Mawatari T, Fukushi JI, Kaibara N, et al., Th1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritis. Ann Rheum Dis 2008; 67: 1299-304.
22. Mullazehi M, Wick MC, Klareskog L, van Vollenhoven R, Ronnelid J,. Anti-type II collagen antibodies are associated with early radiographic destruction in rheumatoid arthritis. Arthritis Res Ther 2012; 14: R100.
23. Nandakumar KS, Holmdahl R,. Efficient promotion of collagen antibody induced arthritis (CAIA) using four monoclonal antibodies specific for the major epitopes recognized in both collagen induced arthritis and rheumatoid arthritis. J Immunol Methods 2005; 304: 126-36.
24. Banda NK, Thurman JM, Kraus D, Wood A, Carroll MC, Arend WP, et al., Alternative complement pathway activation is essential for inflammation and joint destruction in the passive transfer model of collagen-induced arthritis. J Immunol 2006; 177: 1904-12.
25. Banda NK, Hyatt S, Antonioli AH, White JT, Glogowska M, Takahashi K, et al., Role of C3a receptors, C5a receptors, and complement protein C6 deficiency in collagen antibody-induced arthritis in mice. J Immunol 2012; 188: 1469-78.
26. Mancardi DA, Jonsson F, Iannascoli B, Khun H, Van Rooijen N, Huerre M, et al., Cutting edge: the murine high-affinity IgG receptor FcαRIV is sufficient for autoantibody-induced arthritis. J Immunol 2011; 186: 1899-903.
27. Shimaoka T, Seino K, Kume N, Minami M, Nishime C, Suematsu M, et al., Critical role for CXC chemokine ligand 16 (SR-PSOX) in Th1 response mediated by NKT cells. J Immunol 2007; 179: 8172-9.
28. Molon B, Gri G, Bettella M, Gomez-Mouton C, Lanzavecchia A, Martinez AC, et al., T cell costimulation by chemokine receptors. Nat Immunol 2005; 6: 465-71.
29. Gerli R, Bistoni O, Russano A, Fiorucci S, Borgato L, Cesarotti ME, et al., In vivo activated T cells in rheumatoid synovitis: analysis of Th1- and Th2-type cytokine production at clonal level in different stages of disease. Clin Exp Immunol 2002; 129: 549-55.
30. Cooper SM, Sriram S, Ranges GE,. Suppression of murine collagen-induced arthritis with monoclonal anti-Ia antibodies and augmentation with IFN-γ. J Immunol 1988; 141: 1958-62.
31. Boissier MC, Chiocchia G, Bessis N, Hajnal J, Garotta G, Nicoletti F, et al., Biphasic effect of interferon-γ in murine collagen-induced arthritis. Eur J Immunol 1995; 25: 1184-90.
32. Vermeire K, Heremans H, Vandeputte M, Huang S, Billiau A, Matthys P,. Accelerated collagen-induced arthritis in IFN-γ receptor-deficient mice. J Immunol 1997; 158: 5507-13.
33. Kageyama Y, Koide Y, Yoshida A, Uchijima M, Arai T, Miyamoto S, et al., Reduced susceptibility to collagen-induced arthritis in mice deficient in IFN-γ receptor. J Immunol 1998; 161: 1542-8.
34. Irmler IM, Gajda M, Brauer R,. Exacerbation of antigen-induced arthritis in IFN-γ-deficient mice as a result of unrestricted IL-17 response. J Immunol 2007; 179: 6228-36.
35. Waite JC, Skokos D,. Th17 response and inflammatory autoimmune diseases [review]. Int J Inflam 2012: 819467.
36. Nistala K, Moncrieffe H, Newton KR, Varsani H, Hunter P, Wedderburn LR,. Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers. Arthritis Rheum 2008; 58: 875-87.
37. Onishi RM, Gaffen SL,. Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease [review]. Immunology 2010; 129: 311-21.
38. Nakae S, Nambu A, Sudo K, Iwakura Y,. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 2003; 171: 6173-7.
39. Lubberts E, Koenders MI, Oppers-Walgreen B, van den Bersselaar L, Coenen-de Roo CJ, Joosten LA, et al., Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum 2004; 50: 650-9.
40. Van Hamburg JP, Asmawidjaja PS, Davelaar N, Mus AM, Colin EM, Hazes JM, et al., Th17 cells, but not Th1 cells, from patients with early rheumatoid arthritis are potent inducers of matrix metalloproteinases and proinflammatory cytokines upon synovial fibroblast interaction, including autocrine interleukin-17A production. Arthritis Rheum 2011; 63: 73-83.
41. Sarkar S, Cooney LA, White P, Dunlop DB, Endres J, Jorns JM, et al., Regulation of pathogenic IL-17 responses in collagen-induced arthritis: roles of endogenous interferon-γ and IL-4. Arthritis Res Ther 2009; 11: R158.
42. Lee J, Lee J, Park MK, Lim MA, Park EM, Kim EK, et al., Interferon γ suppresses collagen-induced arthritis by regulation of Th17 through the induction of indoleamine-2,3-deoxygenase. PLoS One 2013; 8: e60900.
43. Kryczek I, Wei S, Gong W, Shu X, Szeliga W, Vatan L, et al., Cutting edge: IFN-γ enables APC to promote memory Th17 and abate Th1 cell development. J Immunol 2008; 181: 5842-6.
44. Simons DM, Oh S, Kropf E, Aitken M, Garcia V, Basehoar A, et al., Autoreactive Th1 cells activate monocytes to support regional Th17 responses in inflammatory arthritis. J Immunol 2013; 190: 3134-41.
45. Nistala K, Adams S, Cambrook H, Ursu S, Olivito B, de Jager W, et al., Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment. Proc Natl Acad Sci U S A 2010; 107: 14751-6.
46. Hirota K, Duarte JH, Veldhoen M, Hornsby E, Li Y, Cua DJ, et al., Fate mapping of IL-17-producing T cells in inflammatory responses. Nat Immunol 2011; 12: 255-63.
47. Gunther C, Carballido-Perrig N, Kaesler S, Carballido JM, Biedermann T,. CXCL16 and CXCR6 are upregulated in psoriasis and mediate cutaneous recruitment of human CD8+ T cells. J Invest Dermatol 2012; 132: 626-34.
48. Diegelmann J, Seiderer J, Niess JH, Haller D, Goke B, Reinecker HC, et al., Expression and regulation of the chemokine CXCL16 in Crohn's disease and models of intestinal inflammation. Inflamm Bowel Dis 2010; 16: 1871-81.
49. Borst O, Munzer P, Gatidis S, Schmidt EM, Schonberger T, Schmid E, et al., The inflammatory chemokine CXC motif ligand 16 triggers platelet activation and adhesion via CXC motif receptor 6-dependent phosphatidylinositide 3-kinase/Akt signaling. Circ Res 2012; 111: 1297-307.
50. Isozaki T, Arbab AS, Haas CS, Amin MA, Arendt MD, Koch AE, et al., Evidence that CXCL16 is a potent mediator of angiogenesis and is involved in endothelial progenitor cell chemotaxis: studies in mice with K/BxN serum-induced arthritis. Arthritis Rheum 2013; 65: 1736-46.